Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 19, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - February 19, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

2/19/18 - "Cell Culture Medium and Methods for Enhancing Recombinant Antibody Purity" in Patent Application Approval Process (USPTO 20180030495)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors CHENG, Xiwen; YAN, Chengwei; YANG, Bin; SUEN, Wen-Chen; WENG, Yuancan; DENG, Chongfei, filed on January 13, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents.
2/19/18 - "Compositions and Methods for Transplantation of Colon Microbiota" in Patent Application Approval Process (USPTO 20180028573)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors SADOWSKY, Michael J.; KHORUTS, Alexander; WEINGARDEN, Alexa R.; HAMILTON, Matthew J., filed on June 19, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. Thi
2/19/18 - "Devices for Detection of Antibodies against Therapeutic Drugs" in Patent Application Approval Process (USPTO 20180031569)
"Surprisingly, in the case of many therapeutic drugs which have already been approved for marketing by regulatory authorities and are considered safe by healthcare professionals and patients, often ADA responses to them may result in adverse reactions of varying negative consequences, for example life-threatening IgE- or IgG-mediated anaphylaxis or
2/19/18 - "Etanercept Formulations Stabilized with Xylitol" in Patent Application Approval Process (USPTO 20180028668)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Manning, Mark; Murphy, Brian, filed on September 26, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Coherus Bioscie
2/19/18 - "Method and System for Dose Rate Regulation in Drug Infusion Treatment" in Patent Application Approval Process (USPTO 20180028750)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors DAHLIN, Hans; HOJDMO, Jorgen, filed on January 26, 2016, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compa
2/19/18 - "Methods of Detecting Cancer" in Patent Application Approval Process (USPTO 20180030145)
By a News Reporter-Staff News Editor at Cancer Vaccine Week A patent application by the inventors Soler, David C.; Sloan, Andrew E.; Cooper, Kevin D.; McCormick, Thomas S.; Young, Andrew B., filed on July 28, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondent
2/19/18 - "Panobinostat Dosages for Multiple Myeloma" in Patent Application Approval Process (USPTO 20180028497)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Lin, Rong; Capdeville, Renaud; Grazioli, Laura; Mu, Song; Paul, Sofia; Binlich, Florence, filed on February 17, 2016, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx corresponde
2/19/18 - "Pathology Determination Assistance Device, Method and Storage Medium" in Patent Application Approval Process (USPTO 20180032673)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors KINOSHITA, Moritoshi; HIGASHIYAMA, Ryo; KOGA, Daisuke, filed on September 3, 2014, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is ass
2/19/18 - "Pharmaceutical Compositions" in Patent Application Approval Process (USPTO 20180028548)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors SHAREEF, Mohammad Ajmal; SAHU, Mrutunjaya; HANDA, Ajaykumar, filed on January 12, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application i
2/19/18 - "Pharmaceutical Formulation of Racecadotril" in Patent Application Approval Process (USPTO 20180028448)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Poli, Piero; Fiorino, Alessandro; Piazzolla, Tommaso Roberto, filed on December 23, 2015, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application
2/19/18 - "Pharmaceutical Preparation Comprising Recombinant HcG" in Patent Application Approval Process (USPTO 20180030107)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Cottingham, Ian; Plaksin, Daniel; White, Richard Boyd, filed on May 3, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been
2/19/18 - "Preparation Method for Praziquantel and Intermediate Compounds Thereof" in Patent Application Approval Process (USPTO 20180030049)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors ZHANG, Fuli; YANG, Zhezhou; BAO, Rusheng; XU, Weiwei; BAI, Hua, filed on February 12, 2015, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent applicati
2/19/18 - "System and Method for Monitoring Pharmaceutical Usage" in Patent Application Approval Process (USPTO 20180032699)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Carrender, Curtis L.; Morrisey, Daniel; Sainion, Soneer, filed on July 28, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not
2/19/18 - $-1.15 EPS Expected for Theravance Biopharma, Inc. (TBPH) [Daily News Egypt]
It is negative, as 13 investors sold Theravance Biopharma, Inc. shares while 18 reduced holdings. 7 funds opened positions while 34 raised stakes. 35.46 million shares or 3.52% more from 34.25 million shares in 2017 Q2 were reported. Bnp Paribas Asset Mngmt Holdg Sa has invested 0.05% in Theravance Biopharma, Inc.. Citigroup has 0% invested in Ther
2/19/18 - 60 Pharmaceuticals 60P Receives Priority Review Designation For Malaria Drug
By a News Reporter-Staff News Editor at Pharma Business Week 60 Degrees Pharmaceuticals received Priority Review Designation from the United States Food and Drug Administration for Tafenoquine for prevention of malaria in adults. The FDA informed 60 P of this designation upon filing of its' New Drug Application. TQ has the advantage of a convenie
2/19/18 - Abbott Laboratories Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Feb. 1, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on February 1, 2018. The SEC file number is 0001179110-18-001374.. A U.S. Securities and Exchange Commission filing is
2/19/18 - Abide Therapeutics to Participate in February 2018 Investor Conferences
By a News Reporter-Staff News Editor at Clinical Trials Week Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes, announced that Alan Ezekowitz, CEO and President, will present an overview of the company at the 20th Annual BIO CEO& Investor Confer
2/19/18 - Albireo Pharma, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Feb. 1, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Albireo Pharma, Inc. was posted on February 1, 2018. The SEC file number is 0001140361-18-004481.. A U.S. Securities and Exchange Commission filing i
2/19/18 - Albireo Pharma, Inc. Files SEC Form SC 13D/A, General Statement of Acquisition of Beneficial Ownership: (Feb. 2, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Albireo Pharma, Inc. was posted on February 2, 2018. The SEC file number is 0001140361-18-004769.. A U.S. Securities and Exchange Commission filing i
2/19/18 - Allergan Plc Files SEC Form 8-K, Current Report: (Feb. 1, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on February 1, 2018. The SEC file number is 0001193125-18-028327.. A U.S. Securities and Exchange Commission filing is a form
2/19/18 - Allergan Plc Files SEC Form 8-K, Current Report: (Feb. 5, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on February 5, 2018. The SEC file number is 0001193125-18-031538.. A U.S. Securities and Exchange Commission filing is a form
2/19/18 - Allergan Plc Files SEC Form 8-K, Current Report: (Feb. 6, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on February 6, 2018. The SEC file number is 0001144204-18-005850.. A U.S. Securities and Exchange Commission filing is a form
2/19/18 - Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Period Activity
By a News Reporter-Staff News Editor at Pharma Business Week Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, reported its consolidated financial results for the fourth quarter and full year 2017 and highlighted recent progress in advancing its pipeline. "2017 was a defining inflection point in Alnylam's history, with positi
2/19/18 - Alp Carnitin, a liquid dietary supplement that promotes the healthy reduction of body weight and fat content, debuts on VitaBeauti.com
Alp Nutrition ' s scientific-based, liquid dietary supplement packed with vitamins, minerals, Alp Phyto and L-carnitine to help promote weight loss, Alp Carnitin , is now available on health, wellness and beauty product ecommerce site VitaBeauti.com. Alp Nutrition offers research-based combinations of ingredients in liquid form that are h
2/19/18 - Amag Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Feb. 5, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amag Pharmaceuticals Inc. was posted on February 5, 2018. The SEC file number is 0000792977-18-000005.. A U.S. Securities and Exchange Commission fil
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415